ATXS
Price
$9.74
Change
+$0.19 (+1.99%)
Updated
Dec 18, 10:52 AM (EDT)
78 days until earnings call
KYMR
Price
$42.26
Change
-$0.80 (-1.86%)
Updated
Dec 17, 04:59 PM (EDT)
64 days until earnings call
Ad is loading...

ATXS vs KYMR

Header iconATXS vs KYMR Comparison
Open Charts ATXS vs KYMRBanner chart's image
Astria Therapeutics
Price$9.74
Change+$0.19 (+1.99%)
Volume$200
CapitalizationN/A
Kymera Therapeutics
Price$42.26
Change-$0.80 (-1.86%)
Volume$4.84K
CapitalizationN/A
ATXS vs KYMR Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. KYMR commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and KYMR is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ATXS: $9.55 vs. KYMR: $42.30)
Brand notoriety: ATXS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 109% vs. KYMR: 136%
Market capitalization -- ATXS: $538.95M vs. KYMR: $2.74B
ATXS [@Biotechnology] is valued at $538.95M. KYMR’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 6 bearish.
  • KYMR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than KYMR.

Price Growth

ATXS (@Biotechnology) experienced а -6.00% price change this week, while KYMR (@Biotechnology) price change was -6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.84%. For the same industry, the average monthly price growth was +1.08%, and the average quarterly price growth was +4.66%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 06, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-4.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.74B) has a higher market cap than ATXS($539M). KYMR YTD gains are higher at: 66.143 vs. ATXS (24.349). KYMR has more cash in the bank: 550M vs. ATXS (18.6M). ATXS has less debt than KYMR: ATXS (168K) vs KYMR (88.2M).
ATXSKYMRATXS / KYMR
Capitalization539M2.74B20%
EBITDAN/A-160.96M-
Gain YTD24.34966.14337%
P/E RatioN/AN/A-
RevenueN/A87.6M-
Total Cash18.6M550M3%
Total Debt168K88.2M0%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with IMNM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-1.24%
IMNM - ATXS
44%
Loosely correlated
-3.38%
XENE - ATXS
43%
Loosely correlated
-0.07%
KYMR - ATXS
42%
Loosely correlated
-1.76%
KALV - ATXS
42%
Loosely correlated
-3.35%
BEAM - ATXS
41%
Loosely correlated
-1.21%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with ERAS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.76%
ERAS - KYMR
47%
Loosely correlated
+0.38%
RXRX - KYMR
47%
Loosely correlated
-4.30%
CCCC - KYMR
46%
Loosely correlated
-6.03%
XENE - KYMR
45%
Loosely correlated
-0.07%
OMGA - KYMR
45%
Loosely correlated
+0.15%
More